In conclusion, FRAT1 mRNA and β-catenin protein expression were studied in 60 ovarian adenocarcinomas, including 41 serous, 11 clear cell, five endometrioid and three mucinous adenocarcinomas. This evidence concerns the gene FRAT1 and ovarian adenocarcinoma.